Biocompounds Pharmaceutical Inc.
Welcome to our booth!
2018-CPHI
BioCompounds pharmaceutical Inc. will participate in the 2018 "CPHI world pharmaceutical raw materials China Exhibition" held in Shanghai New International Expo Center from June 20 to 22, 2018, booth number: E2D70. Welcome all friends to our booth.
JUNE
20
Introduction
Biocompounds Pharmaceutical Inc.
Biocompounds Pharmaceutical Inc. (BPI) is an R & D and production enterprise of pharmaceutical raw materials and special chemicals controlled by Jianfeng pharmaceutical under the pharmaceutical section of Jianfeng group (SSE: 600668). It has invested in two factories and is a high-tech enterprise integrating pharmaceutical and pesticide R & D, manufacturing and sales. BPI is a high-tech enterprise in Shanghai, a specialized and special new enterprise in Shanghai, and a pilot enterprise in patent work in Shanghai. It continues to grow with the development of the pharmaceutical industry. Main business：The designated synthesis of APIs and advanced intermediates mainly includes antitumor and non antitumor.（For details of intermediates, please visit the company's official website or click the "read the original text" button at the bottom left of the page to directly link to the company's official website.）
1、Antitumor variety：
Small molecule targeting intermediates
01
Gefitinib
Erlotinib Hydrochloride
Sorafenib
Dasatinib
Lapatinib
Nilotinib
Crizotinib
Bosutinib
Axtintib
Ibrutinib
Ceritinib
Palbociclib
Alkaloid intermediates
02
Paclitaxel
Docetaxel
Irinotecan hydrochloride
Topotecan hydrochloride
Other antitumor intermediates
03
Lenalidomide
Pomalidomide
Capecitabine
Vidarabine
Clofarabine
Decitabine
2、Non antitumor varieties：
Anti osteoporosis intermediates
04
Calcitriol
Paricalcitol
Alfacalcidol
Cardiovascular intermediates
05
Reserpine
Beraprost
Antiviral intermediates
06
Maraviroc
Anti diabetic intermediates
07
Pioglitazone
Antibiotic intermediates
08
Levofloxacin carboxylic acid
Levofloxacin cyclic ester
Oxygen-fluorine acid
Oxyfluoro cyclic ester
R & D Center
▶ Academician expert workstation. Excellent Enterprise Technology Center in Songjiang District. It has a 35 person technical R & D and quality team, including more than 10 doctors and masters.
▶ Two three storey R & D Center buildings including small-scale laboratory, kilogram platform and analysis and testing center；
▶ Temperature: -100℃ ~ 300℃；
▶ Pressure: 0.5 mmHg~10.0 Mpa；
▶ Complete Facilities.
Factory
▶ A fine chemical manufacturing platform with a registered capital of 50 million, covering an area of 118 mu；
▶ With a registered capital of 20 million yuan, it is planned to invest 250 million yuan in chemical medicine MAH customization platform within three years；
▶ 100 sets of 500L ~ 5000L reactors; Complete production facilities；
▶ Perfect safety and environment qualification; Storage and use qualification of hazardous chemicals / highly toxic products.
▶ Good at chlorination, cracking, addition, cyclization and other highly difficult reactions, wastes treatment and automatic equipment.
Exhibition information
《2018-the 18th CPHI in China》
Exhibition hall: Shanghai New International Expo Center
Booth No.: E2D70
Address: No. 2345, Longyang Road, Pudong New Area, Shanghai
Date: June 20-22, 2018
Biocompounds Pharmaceutical Inc.
